Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

5th Annual National Rx Drug Abuse & Heroin Summit Begins March 28 in Atlanta; Speakers include CleanSlate Centers and President Obama
  • USA - English


News provided by

WilMark Group

Mar 25, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

National Rx Drug Abuse & Heroin Summit
National Rx Drug Abuse & Heroin Summit

Atlanta, GA (PRWEB) March 25, 2016 -- Dr. Kelly J. Clark, MD, MBA, DFAPA, DFASAM of CleanSlate Centers will serve as speaker and moderator at the 2016 National Rx Drug Abuse & Heroin Summit, which runs from March 28 through March 31 at The Westin Peachtree Plaza hotel in downtown Atlanta. CleanSlate Centers also is a sponsor. A founding member of the Summit’s Advisory Board, Dr. Clark is the President Elect of the American Society of Addiction Medicine and Chief Medical Officer of CleanSlate Centers.

Our approach at CleanSlate is to treat patients suffering from this disease in a similar manner as we medical professionals approach the treatment of diabetes. We combine a biological, psychological, and social approach.

Post this

The Summit is the largest national collaboration of federal, state and local professionals seeking to address prescription drug abuse, misuse and diversion. This year the Summit has expanded its focus to address the emerging heroin crisis, which has been linked to the prescription drug problem.

Dr. Clark explains CleanSlate’s approach to treatment:
"Addiction is a chronic brain disease. Our approach at CleanSlate is to treat patients suffering from this disease in a similar manner as we medical professionals approach the treatment of diabetes. We combine a biological, psychological, and social approach to treating addiction. This evidenced based care has proven effective in helping those in need to succeed in managing this challenging disorder."

“By bringing together the top professionals across the spectrum, we are advancing a much-needed, multi-faceted approach to combating the drug abuse epidemic across the country,” said Nancy Hale, President/CEO for Operation UNITE, the Summit's organizer. “We are pleased that CleanSlate Centers is a key participant and sponsor. By sharing those resources and expertise, CleanSlate Centers is helping fight this epidemic by working to create a solution that will save lives, families and entire communities.”

More than 1,600 of the nation’s top researchers, law enforcement, advocates and policy-makers will participate.

Dr. Clark will serve as either speaker or moderator for the following summit events:

  • Pre-Summit Workshop: Medication-Assisted Treatment (MAT)
  • Heroin Track: Community Responses to Heroin: North Carolina and Northern Kentucky
  • Clinical Track: Co-Prescribing Opioids and Benzodiazepines: Risks and Recommendations
  • Treatment Track: Buprenorphine: Knocking Out Pill Mills and Minimizing Diversion

President Barack Obama will be in attendance to address the summit due to the national epidemic of opioid addiction.

Other keynote and general session speakers include:

  • Tom Vilsack, Secretary of Agriculture, United States Department of Agriculture
  • U. S. Rep. Harold “Hal” Rogers, R-Kentucky 5th District, Chair, Committee on Appropriations
  • Michael P. Botticelli, Director, White House Office of National Drug Control Policy
  • Dr. Tom Frieden, Director, Centers for Disease Control and Prevention
  • Dr. Francis S. Collins, Director, National Institutes of Health
  • Dr. Robert M. Califf, Commissioner, United States Food and Drug Administration
  • Dr. Eli Capilouto, President, University of Kentucky
  • Dr. Nora D. Volkow, Director, National Institute on Drug Abuse
  • Kana Enomoto, Acting Administrator, Substance Abuse and Mental Health Services

Administration

  • Chuck Rosenberg, Acting Administrator, United States Drug Enforcement Administration
  • A forum featuring Congressional leaders

In addition, break-out sessions will focus on issues such as how drug treatment courts are providing an alternative to incarceration, preventing Hepatitis C and HIV outbreaks, early identification of Neonatal Abstinence Syndrome, and the use of performance-enhancing drugs and ADHD medication among youth. To properly address the issue, the 2016 Summit has expanded the number of breakout sessions to include an educational track focused specifically on heroin-related topics.

The Appalachian Regional Commission and the Centers for Disease Control and Prevention also will have an interactive exhibit for attendees to create six-word stories, snap photos of themselves and their stories at the exhibit photo booth, and share using hashtags #RxSummit and #RxProblem. Those photos, as well as daily coverage of the Summit can be found on the Summit’s Facebook and Twitter social media channels.

For more information on the Summit, visit http://nationalrxdrugabusesummit.org.

Chris Cooney, WilMark Group, +1 4079216932, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.